Haleon

🚨 Reasons for Boycotting Haleon/GSK

Haleon plc (formerly GSK Consumer Healthcare) is a publicly-traded British multinational consumer healthcare company established on 18 July 2022 as a spin-off from GSK, headquartered in Weybridge, England. The company owns globally recognized brands including Sensodyne, Panadol, Advil, Voltaren, Theraflu, Otrivin, and Centrum. Haleon maintains a direct corporate presence in israel, distributes its products in the israeli market, and by refusing to sever ties with israel, it contributes to the normalization of genocide.

1. 100% Haleon Subsidiary in israel: In Haleon plc's SEC filings, Haleon CH israel Ltd (formerly GSK Consumer Healthcare israel Ltd) is registered with 100% effective ownership. Its registered address is 25 Basel Street, Petah Tikva 49510, israel. This subsidiary is official evidence of Haleon's direct corporate presence in israel.SEC Filing: Haleon CH israel Ltd — 100% ownership — 25 Basel Street, Petah Tikva 49510, israel
   
   Operational Presence in israel: Haleon's operations in israel are registered as Petah Tikva-based in the Great Place to Work israel certification, and the company employs 37 people in israel. Haleon is also hiring for a Digital Key Account Manager position to manage its e-commerce channel in israel.Great Place to Work israel: Haleon — Petah Tikva, 37 employeesMisrot: Haleon Digital Key Account Manager — israel
2. GSK/Haleon Product Distribution in israel: Guri A.A.O, one of israel's leading distributors, exclusively distributes GSK/Haleon oral care products (Sensodyne, Parodontax, etc.) in israel. Guri maintains deep relationships with 2,500 of israel's largest supermarkets, pharmacy chains, HMOs, and independent pharmacies. This demonstrates that Haleon products are sold across israel's pharmacies and supermarkets, and the company directly contributes to the israeli economy.MarketScreener: Guri distributes GSK/Haleon oral care products exclusively in israel
3. Institutional Shareholders: BlackRock and Wellington: According to ADVFN data, BlackRock, Inc. is the largest institutional shareholder in Haleon plc with 745,718,619 shares (8.47%). Wellington Management Group LLP is also a significant shareholder with 263,647,879 shares (2.99%). BlackRock and Wellington are identified in a UN report (OHCHR) as being among the largest investors in companies pivotal to israel's weapons arsenal. This means that profits generated by Haleon partly flow to these funds, indirectly contributing to israel's weapons industry.ADVFN: BlackRock 745,718,619 shares (8.47%); Wellington 263,647,879 shares (2.99%)UN OHCHR: Report of the Special Rapporteur Francesca Albanese (2025)
4. Historical and Corporate Connection to GSK: Haleon was established on 18 July 2022 as a spin-off from GSK. GSK reduced its ownership stake in Haleon to 7.4% in October 2023, and further to 4.2% in January 2024. However, Haleon's israeli subsidiary is still registered as Haleon CH israel Ltd, with its former name being GSK Consumer Healthcare israel Ltd. This shows that Haleon inherited GSK's corporate legacy and operational presence in israel.CompaniesMarketCap: Haleon CH israel Ltd (formerly GSK Consumer Healthcare israel Ltd) — 100% ownershipWikipedia: Haleon — GSK reduced ownership to 4.2% in January 2024

🌐 Sources

• SEC Filing: Haleon CH israel Ltd — 100% ownership — Petah Tikva, israel
• Great Place to Work israel: Haleon — Petah Tikva, 37 employees
• MarketScreener: Guri distributes GSK/Haleon products in israel
• ADVFN: BlackRock and Wellington shareholdings in Haleon plc
• CompaniesMarketCap: Haleon CH israel Ltd (formerly GSK Consumer Healthcare israel Ltd)
• UN OHCHR: Report of the Special Rapporteur Francesca Albanese (2025)

Boykot Market has listed the brand information and source links above based on verifiable official sources. Please conduct your own research to be certain.